BSEM
BioStem Technologies, Inc.
Key Financials
Gross Profit
$8.6M
N/A
Revenue
$14.0M
N/A
Net Income
$-17791065
N/A
Total Assets
$48.8M
N/A
Shareholders' Equity
$27.6M
N/A
Cash & Equivalents
$7.0M
N/A
EPS (Diluted)
$-1.04
N/A
Long-term Debt
$0.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-1 | 10/2/2026 | View on SEC |
| 8-K | 9/30/2026 | View on SEC |
| EFFECT | 9/29/2026 | View on SEC |
| 424B3 | 9/29/2026 | View on SEC |
| D | 9/21/2026 | View on SEC |
| S-1 | 9/18/2026 | View on SEC |
| 8-K | 9/18/2026 | View on SEC |
| 4 | 9/17/2026 | View on SEC |
| 4 | 9/17/2026 | View on SEC |
| 4 | 9/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BSEM |
| Company Name | BioStem Technologies, Inc. |
| CIK | 1658678 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | FL |
| Phone | 954-380-8342 |